Adipokines are bioactive signaling molecules secreted by adipose tissue, including hormones (leptin, adiponectin), cytokines (TNF-α, IL-6), chemokines (MCP-1), and metabolic regulators (resistin, visfatin, omentin) that orchestrate systemic metabolism, inflammation, and immune system function. Healthy adipose tissue predominantly secretes anti-inflammatory adipokines (adiponectin, omentin), while dysfunctional adipose tissue shifts toward pro-inflammatory adipokines (TNF-α, IL-6, resistin, leptin excess), driving metaflammation and metabolic syndrome.
Think of adipose tissue as a factory with two production lines. The "metabolic health line" produces helpful messages—adiponectin acts like quality control inspectors that ensure insulin receptors work smoothly, and appropriate leptin signals act like fuel gauge readings sent to headquarters (the hypothalamus). When the factory is well-maintained (healthy adipocytes), these messages dominate.
But when the factory becomes overcrowded (adipocyte hypertrophy), workers get stressed, oxygen runs low (hypoxia), and the "emergency line" takes over. Now the factory churns out distress signals: TNF-α (like alarm bells jamming the insulin receptor locks), IL-6 (mobilization orders that activate inflammation throughout the body), and excessive leptin (fuel gauge stuck screaming "FULL!" even when headquarters stops listening). The factory also starts recruiting security forces (M1 macrophages) that treat the stressed fat cells like invaders, creating a war zone inside the tissue. This shift from helpful coordinator to inflammatory broadcaster is the essence of adipokine dysregulation—the factory's messaging system has been hijacked by stress.
Adipokine secretion is determined by adipocyte size, metabolic state, inflammatory status, and infiltrating immune cells within adipose tissue:
Healthy adipose tissue secretion:
Dysfunctional adipose tissue cascade:
- adipocyte hypertrophy + nutrient excess → ER stress + hypoxia → HIF-1 activation
- HIF-1 → suppresses adiponectin gene transcription + upregulates inflammatory pathways
- Stressed adipocytes → secrete TNF-α, IL-6, MCP-1 (CCL2), leptin excess, resistin
- TNF-α → activates NF-κB and JNK pathways → phosphorylates insulin receptor substrate-1 (IRS-1) at serine residues → blocks insulin signaling → insulin resistance
- MCP-1 → recruits monocytes → differentiate into M1 macrophages → form crown-like structures around dying adipocytes
- M1 macrophages → secrete additional TNF-α, IL-6, IL-1β → amplify inflammatory loop
- IL-6 → circulates systemically → stimulates hepatic acute phase response (↑CRP) → drives vascular inflammation
- Resistin → antagonizes insulin action in liver and muscle → promotes insulin resistance
- Excessive leptin → leptin resistance at hypothalamic receptors → impaired satiety signaling + increased sympathetic tone
graph TD
A[Adipocyte Hypertrophy] --> B["Hypoxia + ER Stress"]
B --> C[HIF-1 Activation]
C --> D["↓ Adiponectin"]
C --> E["↑ TNF-α, IL-6, MCP-1"]
E --> F["NF-κB Activation"]
F --> G[IRS-1 Serine Phosphorylation]
G --> H[Insulin Resistance]
E --> I[Macrophage Recruitment]
I --> J[M1 Polarization]
J --> K[Crown-like Structures]
K --> E
E --> L[Systemic Inflammation]
L --> M[Hepatic Acute Phase Response]
L --> N[Vascular Dysfunction]
D --> O["↓ AMPK Activation"]
O --> H
Receptor specificity:
Adipokine regulation by interventions:
- Exercise → ↑ adiponectin via AMPK activation + PGC-1α → improved mitochondrial function in adipocytes
- Omega-3 fatty acids (EPA/DHA) → activate GPR120 receptor → inhibit NF-κB → ↓ inflammatory adipokines
- Weight loss → reduced adipocyte size → improved oxygenation → ↓ HIF-1 → normalized adipokine profile
- Resolvins → bind ALX-FPR2 receptor → promote M2 macrophages polarization → anti-inflammatory environment
The adipokine profile serves as a direct readout of adipose tissue function and predicts metabolic disease risk independent of body mass index (BMI). Visceral adipose tissue is particularly problematic because it secretes higher levels of inflammatory adipokines than subcutaneous fat and drains directly into the portal circulation, exposing the liver to concentrated inflammatory signals.
Key clinical applications:
Assessment:
Metamodel connections:
- Metamodel 1 (Energy distribution): Adipokines determine whether energy is stored, oxidized, or wasted. TNF-α and resistin shift metabolism toward storage and inflammation rather than oxidation.
- Metamodel 3 (Selfish systems): The selfish immune system hypothesis predicts adipokine dysregulation—immune cells within adipose tissue prioritize their own survival (extracting nutrients, recruiting reinforcements) at the expense of metabolic health.
- Evolutionary mismatch: Chronic nutrient excess is evolutionarily novel. The inflammatory adipokine response evolved to mobilize immune resources during infection-induced cachexia, not to respond to persistent adipocyte stress from overnutrition.
Disease mechanisms:
Intervention strategies:
- Weight loss (7-10% body weight) → reduces adipocyte size → restores oxygenation → ↑ adiponectin, ↓ TNF-α, IL-6
- Exercise → ↑ adiponectin independent of weight loss through AMPK activation; even 150 min/week moderate activity shifts profile
- Omega-3 supplementation (2-3g EPA+DHA daily) → GPR120 activation → ↓ inflammatory adipokines
- Resolvins and specialized pro-resolving mediators → promote resolution of adipose tissue inflammation → M2 macrophages dominance
- Intermittent fasting → reduces ER stress in adipocytes → ↓ HIF-1 activation → normalized secretion
- Anti-inflammatory diet (Mediterranean pattern) → ↓ NF-κB activation → improved adipokine balance
Monitoring response to therapy:
- adiponectin should increase by 20-30% with successful lifestyle intervention
- leptin should decrease proportionally to fat mass loss (approximately 3-5 ng/mL per kg fat lost)
- CRP (as hepatic readout of IL-6) should fall below 3 mg/L, ideally <1 mg/L
- Over 600 different proteins secreted by adipose tissue identified, but major metabolic adipokines include leptin, adiponectin, resistin, visfatin, omentin, TNF-α, IL-6, MCP-1
- leptin concentration directly proportional to fat mass: approximately 3-5 ng/mL per kilogram of body fat
- adiponectin inversely related to adiposity and insulin resistance; levels 5-30 μg/mL (healthy range: >10 μg/mL men, >15 μg/mL women)
- Visceral adipose tissue produces 2-3× more IL-6 and TNF-α per gram than subcutaneous fat
- 30% of circulating IL-6 originates from adipose tissue in obesity (normally <10%)
- TNF-α from stressed adipocytes causes up to 50% of obesity-related insulin resistance through IRS-1 serine phosphorylation
- Resistin links obesity to diabetes: levels 10-15 ng/mL in obesity vs 5-8 ng/mL in lean individuals
- adiponectin:leptin ratio <0.5 predicts metabolic syndrome with 85% sensitivity
- Each 1 μg/mL increase in adiponectin associated with 6% lower diabetes risk
- Exercise increases adiponectin by 15-30% within 12 weeks, independent of weight loss
- Omega-3 fatty acids increase adiponectin and decrease TNF-α within 8-12 weeks of supplementation (2g+ EPA/DHA daily)
- Crown-like structures (M1 macrophages surrounding dead adipocytes) correlate directly with systemic inflammation and insulin resistance
- adipose tissue — endocrine organ secreting all adipokines; function determines secretory profile
- Adipocytes — primary cellular source; adipocyte size and metabolic state control adipokine production
- leptin — master adipokine signaling energy stores to brain; excess drives leptin resistance
- adiponectin — key anti-inflammatory, insulin-sensitizing adipokine; inversely related to metabolic disease
- TNF-α — pro-inflammatory adipokine causing insulin resistance via IRS-1 serine phosphorylation
- IL-6 — dual-role adipokine (30% from adipose in obesity); drives hepatic acute phase response
- insulin resistance — directly caused by TNF-α, resistin, and leptin excess; improved by adiponectin
- Metaflammation — chronic metabolic inflammation driven by dysfunctional adipokine secretion
- metabolic syndrome — defined by pro-inflammatory adipokine profile and low adiponectin
- adipocyte hypertrophy — primary driver shifting adipokine balance toward inflammation
- hypoxia — occurs in hypertrophied adipose tissue; activates HIF-1 → suppresses adiponectin, increases inflammatory signals
- M1 macrophages — recruited by MCP-1 from stressed adipocytes; form crown-like structures and amplify inflammatory adipokines
- M2 macrophages — promote adipose tissue health; increased by resolvins, exercise, weight loss
- NF-κB — central transcription factor activated by TNF-α and other inflammatory adipokines
- aromatase — upregulated in dysfunctional adipose tissue by inflammatory adipokines; converts androgens to estrogens
- breast cancer — adipokines (high leptin, low adiponectin) link obesity to cancer through estrogen and growth factor pathways
- type 2 diabetes — adipokine dysregulation is primary mechanism connecting obesity to diabetes
- cardiovascular disease — inflammatory adipokines (IL-6, TNF-α) promote atherosclerosis and endothelial dysfunction
- AMPK — activated by adiponectin; master regulator of energy metabolism and mitochondrial biogenesis
- HIF-1 — induced by adipose tissue hypoxia; suppresses adiponectin and activates inflammatory pathways
- Exercise — directly improves adipokine profile through AMPK activation and reduced adipocyte stress
- resolvins — Specialized pro-resolving mediators (SPMs) that reprogram adipose tissue macrophages toward resolution
- omega-3 fatty acids — precursors to resolvins; activate GPR120 to suppress inflammatory adipokine production
- chronic low-grade inflammation — sustained by pro-inflammatory adipokine excess from dysfunctional adipose tissue
- JAK-STAT — signaling pathway for leptin and IL-6; activation leads to SOCS3 feedback inhibition
- intermittent fasting — reduces adipocyte ER stress and improves adipokine secretion pattern
- obesity — characterized by adipokine dysregulation; visceral obesity particularly problematic
- hypothalamus — receives adipokine signals, especially leptin; develops resistance with chronic elevation
- PPARα — activated by adiponectin; promotes fatty acid oxidation and anti-inflammatory gene expression
- Alzheimer's Disease — peripheral adipokine signals (especially leptin resistance and TNF-α) contribute to neurodegeneration
- Module 1: Adipose tissue as endocrine organ; adipokine secretion patterns
- Module 5: Metabolic regulation and inflammatory signaling through adipokines